Vitamin D and Omega-3 Ineffective for Preventing Cancer and Heart Disease (too little was used)
Vitamin D and Fish Oils Are Ineffective for Preventing Cancer and Heart Disease
Reported by New York Times
π Download the Presented PDF from VitaminDWiki
Update - analysis of VITAL Trial
When the VITAL trial was started VitaminDWiki, and many others, predicted
that it would be unlikely to find a benefit
Vitamin D trials underway are unlikely to be useful β Jan 2015
-
40 years ago it might have been enough
2,000 IU of vitamin D might have been enough for some people to get a benefit (that is, achieve >30 ng level of vitamin D)
But not for overweight, poor gut, dark skin, many seniors, and others who are at high risk of having low levels of vitamin D
0.84 gram of Omega-3 used by VITAL might have produced a benefit before
- but now people consume a lot of Omega-6 (which blocks the benefits of Omega-3)
There used to be a lot more Magnesium in the diet
See also Omega-3 in VitaminDWiki
-
- Gave 1.6 grams (1.9X) of Omega-3
Omega-3 provides many cardiovascular benefits β April 2018
- Gave 4 grams (4.8X) of Omega-3
Omega-3 helps the heart, AHA class II recommendation, more than 1 gm may be needed β March 2018
I use Vectomega brand of Omega-3 β Admin of VitaminDWiki, May 2014
- Some Omega-3's are far more bio-available than others and produce higher Omega-3 index test results
Breast Cancer rate reduced by 40 percent with Omega-3 β meta-analysis June 2013
Low-Grade Prostate Cancer 70 percent less likely to progress if good level of Omega-3 β June 2018
Omega-3 RDAs around the world: 100 to 2400 mg per day, US still has no RDA β Dec 2018
See also VitaminDWiki
Small or infrequent doses of vitamin D do not reduce heart failure much β meta-analysis Jan 2018
Vitamin D repletion = 2000 IU daily for adults and 5000 IU daily for seniors May 2010
Vitamin D levels have been crashing
See also Omega-3 in the web
Over 1,000 Omega-3 intervention clinical trials listed as of Nov 2018
126 on-going clinical trials with Omega-3 intervention for seniors as of Nov 2018
- Example trial: Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction (OMEMI) - is using 1.8 grams of Omega-3
Comments on the VITAL study
Beware of false propaganda against supplements like vitamin D3
described the things wrong with VITAL study - from Norway
- Too short of trial for Cancers, too little vitamin D, too little Omega-3
- "...current study appears as part of the D3 promotional campaign launched by Big Pharma"
- π Download the Translated PDF from VitaminDWiki
Making sense of the VITAL study - Donβt write off vitamin D just yet! Dec 2018 Vitamin D Society
Dr. Rhonda Patrick video (FoundMyFitness)
There were some negative results that made headlines but there were also a lot of positive results as well. Let's talk about them!
WATCH THE YOUTUBE VIDEO BY CLICKING HERE
It was an randomized controlled trial involving more than 25,800 people that were randomly assigned to one of four groups: one received 2,000 IU of vitamin D a day and a placebo, another took 1g of omega-3 fatty acids a day with a placebo, a third took both 2,000 IU of vitamin D and 1g of omega-3 a day, and the last group received two daily placebos. All volunteers took their assigned nutrients for approximately five years, and researchers logged everything from cancer diagnoses to major heart events including heart attack and stroke, as well as deaths from cancer and heart disease.
The large omega-3 and vitamin D trial found no difference between omega-3 and placebo for adverse heart outcomes combined (heart attack + stroke) but it did find that fish oil reduced heart attack risk by 28% and 40% in people with low fish intake compared to placebo. The large omega-3 and vitamin D trial found no difference between omega-3 and placebo for adverse heart outcomes combined but it did find that fish oil reduced heart attack risk by 28% and 40% in people with low fish intake (less than 1.5 servings per week) compared to placebo. The reduction of heart attack risk among those taking omega-3s was especially pronounced among African American participants, with a 77% reduction was observed.
As for vitamin D no effect was found on heart attacks. There was a non-significant difference in reduced cancer rates compared to placebo. However, when the team examined rates after participants had been taking supplements for at least two years, they found that cancer deaths were significantly reduced by 25 percent among those taking vitamin D .
No serious side effects, such as bleeding, high blood calcium levels, or gastrointestinal symptoms were found with either supplement. The two supplements did not appear to interact with each other or have synergistic effects.
